Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
RBC Capital Markets has begun analyst coverage of five major European pharmaceutical companies, assigning Outperform ratings to Roche and AstraZeneca and Sector Perform to Novartis, GSK and Sanofi. The bank assigned specific price targets and cited pipeline dynamics, recent trial setbacks and patent-expiry pressures as key factors shaping its views…
Nano-X Imaging Ltd announced its Q2 2026 financial results with revenues rising 37% year-over-year driven by its Nanox Health IT acquisition. The company expanded U.S. and Latin American distribution, launched its first Nanox Imaging Network site, and advanced AI-based solutions commercial momentum. It undertook a restructuring of Korean operations…
Amazon is preparing to raise 4 billion pounds in its inaugural sterling bond sale, a four-part transaction that attracted more than 12 billion pounds of demand, according to a lead manager involved in the deal. The offering reflects a broader move by hyperscalers to tap markets outside the United States to finance expanding capital needs tied to ar…
SIFCO Industries has quietly moved from loss-making quarters into consistent profitability, with improving margins, positive free cash flow and low leverage. The market is focused on flat revenue and a high P/E; we see a path to rerating if margins hold and backlog or aftermarket demand accelerates. This is a tactical long trade with defined entry,…
Nvidia ($225.78) is more than a GPU vendor today. Its DGX Cloud, Omniverse, vGPU, and high-performance networking form an alternative AI stack that lets enterprises and cloud builders build outside AWS/GCP/Azure. Strong cash generation (FCF $127B) and high returns (ROE ~84%) justify a premium valuation, but competition, custom silicon, and executio…
HP Inc. announced a collaboration with Red Hat and NVIDIA to develop an open, enterprise-grade AI platform combining HP's ZGX Fury hardware with Red Hat AI Factory and NVIDIA's AI technology. This platform is designed to run AI inference closer to users, machines, and data, enabling improved AI performance, reduced setup times, and enhanced operati…
Quantum-Si is expanding its Proteus roadshow with additional stops in both the United States and Europe to advance market education and customer engagement ahead of the commercial launch of its single-molecule protein sequencing platform. The roadshow includes seminars in collaboration with academic, clinical, and biopharma partners, targeting rese…
WW International, Inc., known for its science-backed weight management programs, announced the appointment of Stephen Bye as its new President and CEO. Bye brings over 30 years of leadership experience in consumer subscription and technology businesses, having previously led Ookla and held senior roles at DISH Network, Sprint, and others. His exper…
Incannex Healthcare has started dosing patients in its Phase 2 dose-optimization trial (DReAMzz) of IHL-42X for obstructive sleep apnea, following positive prior Phase 2 data and FDA Fast Track designation. The company also received a US patent covering IHL-42X composition expiring in 2040 and holds approximately $70 million in cash with no debt. A…
Firefly Aerospace has signed a multi-launch agreement with SSC Space for two launches of its Alpha rocket from Sweden's Esrange Space Center targeted for no earlier than 2028. This deal provides Sweden and European customers with new orbital launch services from mainland Europe and marks the start of a long-term partnership between Firefly and SSC …
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company focused on CNS cancer therapies, announced a $15 million registered direct offering of common stock and warrants at a combined price of $4.20 per share. The offering targets new and existing healthcare-focused institutional investors and is expected to close around Septem…
PowerCompute, Inc. provided an operational update for August 2026, highlighting consistent Bitcoin mining production of 7.9 BTC, energy sales generated through power curtailment amounting to approximately $132,000, and bitcoin holdings value of $25.2 million. The company is advancing its mining capabilities by ordering 1,000 new miners, anticipatin…
IN8bio, a clinical-stage biopharmaceutical company focused on γδ T cell therapies, has appointed Dr. Oxana Polyakova as Senior Vice President of Research & Development. Dr. Polyakova brings two decades of expertise in γδ T cell biology and T cell engager therapeutics, strengthening IN8bio's leadership as they advance their pipeline targeting oncolo…
Ascent Solar Technologies has appointed Tom Bawol as Director of Strategic Sales & Market Development and LTG Steve Smith as Strategic Advisor, bringing extensive military leadership and business development experience. These appointments aim to accelerate the commercial adoption of Ascent's flexible thin-film photovoltaic solutions in markets such…
Jasper Therapeutics, a clinical stage biotech company focusing on immune-mediated disease therapies, announced its upcoming presentation at the H.C. Wainwright 28th Annual Global Investment Conference. Management will participate in a fireside chat to discuss the company's pipeline and clinical progress.
Adagene Inc., a clinical-stage biotechnology company, announced the achievement of a preclinical milestone with Exelixis relating to its SAFEbody platform. This milestone pertains to the development of XB404, an antibody-drug conjugate targeting ROR1/2-expressing tumors, which triggered a $2 million payment from Exelixis. Additional payments were a…
Asure Software's 2026 HR Benchmark Report reveals that small business owners are increasingly uncertain about their compliance with employment laws, especially those experiencing downturns. The company emphasizes that growing businesses are more proactive in HR best practices and promotes its AsureWorks managed service to help alleviate compliance …
red violet, Inc.'s subsidiary FOREWARN has announced a collaboration with Pacific West Association of REALTORS® to provide FOREWARN's real-time identity verification services to over 10,000 members across California. The service, accessible online and via mobile app, enables real estate agents to verify identities, check criminal histories, and val…
Merlin, Inc. announced a strategic pivot to pursue civil certification and deployment of its autonomous flight technology for large aircraft instead of small ones. Building on its defense sector success with programs like the C-130J autonomy project, Merlin aims to address the large commercial aircraft market, where pilot shortages and operational …
Academy Sports and Outdoors, Inc. reported a 3% increase in net sales for the second quarter of fiscal 2026, with diluted GAAP EPS rising 17.3% to $2.17 and adjusted EPS up 19.1% to $2.31. The company opened three new stores and expanded eCommerce sales by 12.8%. Academy reaffirmed its fiscal 2026 sales guidance while increasing EPS expectations, h…
Aktis Oncology, a clinical-stage cancer therapy company specializing in targeted radiopharmaceuticals, announced CEO Matthew Roden's participation in two major investor conferences in September 2026 to present their innovative radioconjugate platform and clinical programs. The company highlighted its proprietary miniprotein platform, clinical trial…
NANO Nuclear Energy Inc. (NASDAQ: NNE) announced the appointment of Marilyn Diaz, a seasoned nuclear regulatory executive with 17 years at the U.S. Nuclear Regulatory Commission, as Director of Fuel Facilities Operations. Diaz's expertise in nuclear fuel facility regulation and advanced reactor policy is expected to strengthen NANO Nuclear's vertic…
Bakkt, Inc. announced the expansion of its global commercial team to accelerate the scaling of its digital asset infrastructure and payments platform. The company raised its 2026 Total Transacting Volume target from $2.5 billion to $3 billion, reflecting increased customer demand and a strong pipeline. Bakkt is also developing product suites target…
MBX Biosciences, a clinical-stage biopharmaceutical company specializing in precision peptide therapies for endocrine and metabolic disorders, announced its CEO and CMO will present at the Morgan Stanley 24th Annual Global Healthcare Conference and the Stifel 2026 Virtual Cardiometabolic Forum. The company provides webcast access to these events th…
Humacyte announced FDA authorization to extend the shelf life of its bioengineered vascular product, Symvess, from 18 months to 36 months, supported by stability data. This extension facilitates better inventory management, reduces waste, and enhances hospital adoption of Symvess. Symvess is FDA-approved for urgent extremity vascular trauma and is …
